GCT-Project:
Pioneering Molecular Surgery with CRISPR Technologies for Personalized Lung Cancer Therapy
More InformationThe first tandems for the new funding line were selected in January 2025 and began their two-year funding period in spring 2025. The tandem partners come from Dresden, Erlangen, Hanover, Berlin, and Mainz and introduce themselves and their projects below.